No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs138989341 |
chr1:46268612-46268613 |
Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs547907063 |
chr1:46268641-46268642 |
Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs76571973 |
chr1:46268693-46268694 |
Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs79640125 |
chr1:46268700-46268701 |
Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs149881040 |
chr1:46268712-46268713 |
Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs551740576 |
chr1:46268734-46268735 |
Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs570374536 |
chr1:46268735-46268736 |
Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs537807642 |
chr1:46268744-46268745 |
Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs117439224 |
chr1:46268759-46268760 |
Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs549779893 |
chr1:46268776-46268777 |
Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs568095170 |
chr1:46268814-46268815 |
Active TSS Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs535535491 |
chr1:46268831-46268832 |
Active TSS Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs553878504 |
chr1:46268861-46268862 |
Active TSS Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs572096928 |
chr1:46268884-46268885 |
Active TSS Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs539627128 |
chr1:46268886-46268887 |
Active TSS Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs137888816 |
chr1:46269081-46269082 |
Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Enhancers
|
TF binding regionChromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs11211191 |
chr1:46269132-46269133 |
Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
18 |
rs372503478 |
chr1:46269143-46269144 |
Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs543342197 |
chr1:46269145-46269146 |
Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs371513995 |
chr1:46269222-46269223 |
Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs573740933 |
chr1:46269254-46269255 |
Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs541164610 |
chr1:46269276-46269277 |
Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs559800840 |
chr1:46269283-46269284 |
Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs533324732 |
chr1:46269302-46269303 |
Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs552873077 |
chr1:46269320-46269321 |
Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs12081398 |
chr1:46269352-46269353 |
Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs531213996 |
chr1:46269430-46269431 |
Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs374873750 |
chr1:46269626-46269627 |
Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs540929195 |
chr1:46269680-46269681 |
Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs56303620 |
chr1:46269711-46269712 |
Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs112226281 |
chr1:46269729-46269730 |
Active TSS Weak transcription Enhancers
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs535432470 |
chr1:46269817-46269818 |
Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs113721451 |
chr1:46269859-46269860 |
Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs376025405 |
chr1:46269883-46269884 |
Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs565782029 |
chr1:46269934-46269935 |
Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs539227945 |
chr1:46269943-46269944 |
Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs557915639 |
chr1:46269952-46269953 |
Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs77028111 |
chr1:46270051-46270052 |
Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs569547839 |
chr1:46270073-46270074 |
Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS
|
Chromatin interactive region
|
7 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs4434876 |
chr1:46270129-46270130 |
Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS
|
Chromatin interactive region
|
6 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
41 |
rs577607098 |
chr1:46270159-46270160 |
Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS
|
Chromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs555292715 |
chr1:46270208-46270209 |
Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs546460166 |
chr1:46270244-46270245 |
Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs184605259 |
chr1:46270283-46270284 |
Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs372855362 |
chr1:46270333-46270334 |
Active TSS Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs189508790 |
chr1:46270402-46270403 |
Active TSS Weak transcription Flanking Active TSS Enhancers
|
Chromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs76912510 |
chr1:46270432-46270433 |
Active TSS Weak transcription Flanking Active TSS Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs563057480 |
chr1:46270451-46270452 |
Active TSS Weak transcription Flanking Active TSS Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs559556465 |
chr1:46270588-46270589 |
Active TSS Weak transcription Flanking Active TSS Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs181453295 |
chr1:46270646-46270647 |
Active TSS Weak transcription Flanking Active TSS Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|